Chih Hung Yeh
Chief Executive Officer chez TAIWAN LIPOSOME COMPANY, LTD.
Postes actifs de Chih Hung Yeh
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TAIWAN LIPOSOME COMPANY, LTD. | Director/Board Member | - | - |
| Chief Executive Officer | - | - | |
| President | 01/03/2002 | - | |
| STEMINENT BIOTHERAPEUTICS, INC | Director/Board Member | 08/12/2021 | - |
| TLC Biopharmaceuticals, Inc. | Corporate Officer/Principal | - | - |
| TLC Biopharmaceuticals HK Ltd. | Director/Board Member | - | - |
| TLC Biopharmaceuticals B.V. | Chief Executive Officer | - | - |
| TLC Biopharmaceuticals Shanghai Ltd. | Director/Board Member | - | - |
| Chief Executive Officer | - | - | |
| TLC Biopharmaceuticals Pty Ltd. | Director/Board Member | - | - |
| TLC Biopharmaceuticals Japan Co., Ltd. | Director/Board Member | - | - |
| President | - | - | |
Woods Investment Co. Ltd.
 Woods Investment Co. Ltd. Financial ConglomeratesFinance Woods Investment Co. Ltd. provides investment services. The private company is based in Taipei, TW. and has a global presence of subsidiaries in several regions. Woods Investment Co. was founded in 2021. | Director/Board Member | - | - |
Historique de carrière de Chih Hung Yeh
Anciens postes connus de Chih Hung Yeh
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formation de Chih Hung Yeh
| University of California, Berkeley | Undergraduate Degree |
| University of Michigan | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Taïwan | 4 |
| Hong Kong | 2 |
Opérationnelle
| Director/Board Member | 7 |
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 3 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| STEMINENT BIOTHERAPEUTICS, INC | Health Technology |
| Entreprise privées | 11 |
|---|---|
| General Bank | Finance |
Taiwan Liposome Co., Ltd.
 Taiwan Liposome Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiwan Liposome Co., Ltd. engages in the research and development of lipid-based formulation drugs. Its products are used for pain management, eye disease treatment, and cancer treatment. The company was founded by Kee Lung Hong on November 10, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
Hermes Biosciences, Inc.
 Hermes Biosciences, Inc. BiotechnologyHealth Technology Hermes Biosciences, Inc. develops innovative targeted drug delivery technologies for therapeutic and other biomedical applications. The company was founded by John W. Park, James D. Marks, Keelung Hong and Christopher Benz and is headquartered in South San Francisco, CA. | Health Technology |
| Asiawired Group | |
| TLC Biopharmaceuticals, Inc. | |
| TLC Biopharmaceuticals HK Ltd. | |
| TLC Biopharmaceuticals B.V. | |
| TLC Biopharmaceuticals Shanghai Ltd. | |
| TLC Biopharmaceuticals Pty Ltd. | |
| TLC Biopharmaceuticals Japan Co., Ltd. | |
Woods Investment Co. Ltd.
Woods Investment Co. Ltd. Financial ConglomeratesFinance Woods Investment Co. Ltd. provides investment services. The private company is based in Taipei, TW. and has a global presence of subsidiaries in several regions. Woods Investment Co. was founded in 2021. | Finance |
- Bourse
- Insiders
- Chih Hung Yeh
- Expérience
